Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Transfection Technologies Market Outlook

The global transfection technologies market size was valued at USD 1,137.62 million in 2023, driven by the development of non-viral delivery systems across the globe. The market size is anticipated to grow at a CAGR of 8.50% during the forecast period of 2024-2032 to achieve a value of USD 2,370.64 million by 2032.

Transfection Technologies: Introduction

Transfection technologies are the techniques and methods that are used to introduce foreign genetic material into cells such as DNA and RNA. These technologies are widely used in gene therapies, drug discovery, and biotechnology. There are several merits and demerits of each transfection method available. Transfection can be achieved through viral or non-viral delivery systems. The most commonly used techniques are chemical transfection, electroporation, and viral-mediated transfection.

Transfection technologies are advancing in our understanding of genetics, facilitating drug discovery, and contributing to the development of innovative therapies. The continuous evolution and optimization of transfection methods contribute to the ongoing breakthroughs in molecular biology and can potentially participate in future advancements in fields such as gene therapy, regenerative medicine, and precision medicine.

Global Transfection Technologies Market Analysis

There are several key trends in the market including the development of non-viral delivery systems which are gaining popularity due to their improved safety profiles and ease of use compared to viral vectors. Additionally, gene editing technologies, cell-specific transfection, high throughput transfection, application specific transfection are also key trend contributing to the global transfection technologies market expansion.

Enhancing cell survival, decreasing, cytotoxicity, and, improving transfection efficiency are the main goals of ongoing research and development. The development of transfection methods that allow for the simultaneous transfection of numerous wells or cell arrays is a result of the necessity for high-throughput screening and analysis in drug discovery and functional genomics. Transfection procedures can be improved and standardized due to the growing integration of transfection technologies with laboratory automation systems, which is likely to aid the transfection technologies market growth. Automated transfection platforms allow accurate and reliable transfection across numerous samples, boosting throughput and reproducibility and accelerating market growth.

Global Transfection Technologies Market Segmentations

Market Breakup by Method

  • Reagent-based Method 
  • Instrument-based Method 
  • Other Methods

Market Breakup by Application

  • Biomedical Research 
  • Therapeutic Delivery 
  • Protein Production

Market Breakup by Products

  • Reagent 
  • Instrument 
  • Others

Market Breakup by End User

  • Pharmaceutical and Biotechnology Companies 
  • Contract Research Organizations 
  • Academic and Research Institutes

Market Breakup by Region

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

Global Transfection Technologies Market Overview

The market for transfection technologies has witnessed significant growth in recent years, and is expected to grow in coming years as well. The growth of the market is driven by the increasing demand for genetic research, drug discovery, and gene therapy applications. The market offers a range of transfection methods, including viral and non-viral delivery systems.

The transfection technologies market development is driven by the increasing focus on genetic research which includes functional genomics, proteomics, and personalized medicine. The increasing emphasis on genetic research, including genomics, proteomics, and personalized medicine is driving the demand for transfection technologies propelling the market growth. Recombinant proteins, monoclonal antibodies, and gene treatments are among the biopharmaceuticals that are in high demand. By facilitating the entry of recombinant DNA constructs into host cells for protein expression, transfection technologies play a crucial role in the manufacture of these complex biologics.

Transfection Technologies Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Lonza Group 
  • Bio-Rad Laboratories, Inc. 
  • Thermo Fisher Scientific 
  • Qiagen NV 
  • Promega Corporation 
  • SignaGen Laboratories 
  • Merck KGaA 
  • Altogen Biosystems 
  • Polyplus-transfection SA 
  • Mirus Bio

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Method
  • Application
  • Products
  • End User
  • Region
Breakup by Method
  • Reagent-based Method 
  • Instrument-based Method 
  • Other Methods
Breakup by Application
  • Biomedical Research 
  • Therapeutic Delivery 
  • Protein Production
Breakup by Products
  • Reagent 
  • Instrument 
  • Others
Breakup by End User
  • Pharmaceutical and Biotechnology Companies 
  • Contract Research Organizations 
  • Academic and Research Institutes
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Lonza Group 
  • Bio-Rad Laboratories, Inc. 
  • Thermo Fisher Scientific 
  • Qiagen NV 
  • Promega Corporation 
  • SignaGen Laboratories 
  • Merck KGaA 
  • Altogen Biosystems 
  • Polyplus-transfection SA 
  • Mirus Bio

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 1,137.62 million in 2023, driven by the increasing genetic research.

The market is anticipated to grow at a CAGR of 8.50% during the forecast period of 2024-2032 and reach a market value of USD 2,370.64 million by 2032.

The increasing demand for genetic research is major drivers for the transfection technologies market.

The development of non-viral delivery systems, and technological advancement in the market are among the major key trends for the market.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The products in the market include reagents, instruments among others.

The different methods in the market include reagent-based method, instrument-based method among other methods.

The different applications of transfection technologies include biomedical research, therapeutic delivery, protein production.

The end users of the transfection technologies include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes.

Key players involved in the market are Lonza Group, Bio-Rad Laboratories, Inc. Thermo Fisher Scientific, Qiagen NV, Promega Corporation, SignaGen Laboratories, Merck KGaA, Altogen Biosystems, Polyplus-transfection SA, and Mirus Bio.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124